Akoya Reports Fourth Quarter and Full Year 2021 Operating Results and Provides 2022 Financial Outlook
14 mars 2022 16h05 HE
|
Akoya Biosciences, Inc.
Q4 2021 revenue $16.2 million and FY 2021 revenue $54.9 millionFY 2022 revenue guidance $69 - 71 million MARLBOROUGH, Mass., March 14, 2022 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq:...
Akoya to Report Fourth Quarter and Full Year 2021 Financial Results on March 14th, 2022 and Present at the Cowen Annual Health Care Conference on March 8th, 2022
22 févr. 2022 08h00 HE
|
Akoya Biosciences, Inc.
MARLBOROUGH, Mass., Feb. 22, 2022 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that it will release financial results for the...
Akoya Biosciences to Present at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
03 févr. 2022 08h00 HE
|
Akoya Biosciences, Inc.
MARLBOROUGH, Mass., Feb. 03, 2022 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that it will be virtually participating in the...
Akoya Biosciences Appoints Marilee Moy as Chief People Officer
20 janv. 2022 08h05 HE
|
Akoya Biosciences, Inc.
MARLBOROUGH, Mass., Jan. 20, 2022 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced the appointment of Marilee Moy as Chief People...
Akoya Biosciences Announces Commercial Launch of PhenoCycler-Fusion, the Fastest Single-Cell Spatial Biology System
13 janv. 2022 08h05 HE
|
Akoya Biosciences, Inc.
MARLBOROUGH, Mass., Jan. 13, 2022 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc., (Nasdaq: AKYA), The Spatial Biology Company®, today announced the commercial availability of the PhenoCycler™-Fusion...
Akoya Announces Preliminary Financial Results for the Fourth Quarter and Full Year 2021
10 janv. 2022 08h00 HE
|
Akoya Biosciences, Inc.
MARLBOROUGH, Mass., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced preliminary unaudited revenue for the fourth...
Akoya Biosciences and Bio-Techne Partner to Deliver Automated Spatial Multiomics Workflow with Industry-Leading Speed and Resolution
05 janv. 2022 07h00 HE
|
Akoya Biosciences, Inc.
MARLBOROUGH, Mass. and MINNEAPOLIS, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc., (NASDAQ: AKYA), The Spatial Biology Company®, and Bio-Techne (NASDAQ: TECH), a global life sciences...
Akoya Biosciences to Present at the 40th Annual J.P. Morgan Healthcare Conference
04 janv. 2022 08h05 HE
|
Akoya Biosciences, Inc.
MARLBOROUGH, Mass., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that it will be virtually participating in the...
Akoya Biosciences Unveils Comprehensive Roadmap of Innovations at Inaugural Spatial Day Event
15 déc. 2021 12h00 HE
|
Akoya Biosciences, Inc.
-Company previews an integrated suite of solutions, including the new PhenoCycler™-Fusion System for unbiased spatial discovery, at unprecedented speeds -Innovations include a novel spatial...
Akoya Biosciences Announces a Groundbreaking Collaboration with PathAI to Combine Spatial Biology with AI-Powered Tools to Facilitate Discovery of Novel Predictive Biomarkers
13 déc. 2021 08h05 HE
|
Akoya Biosciences, Inc.
MARLBOROUGH, Mass., Dec. 13, 2021 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc., (Nasdaq: AKYA), The Spatial Biology Company®, and PathAI, a global leader in artificial intelligence (AI)-powered...